Gloria Melanie

Chief Operating Officer

Gloria Melanie has filed 9 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Oct 9, 2026.

On the most recent filing, Gloria Melanie is listed as Chief Operating Officer at Immunovant, Inc. Inside the rolling window, Gloria Melanie reported no open-market purchases and 8 open-market sales totaling $1.7M in IMVT. The largest disclosed transaction in the window is a sale of 17,714 IMVT shares on Jun 26, 2026, worth $679K.

Companies traded

Other insiders at IMVT

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.7M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
IMVTSale$72KOct 9SEC ↗
IMVTSale$135KAug 21SEC ↗
IMVTSale$81KJul 10SEC ↗
IMVTSale$679KJun 26SEC ↗
IMVTSale$101KMay 22SEC ↗
IMVTSale$217KApr 10SEC ↗
IMVTSale$90KFeb 27SEC ↗
IMVTSale$298KNov 21SEC ↗
Showing 1–8 of 8
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Gloria Melanie made?

Gloria Melanie has filed 9 SEC Form 4 filings (16 transaction rows) across 1 company since 2025.

Which companies does Gloria Melanie trade?

Gloria Melanie has filed SEC Form 4 disclosures for 1 company, including IMVT.

When was Gloria Melanie's most recent SEC Form 4 filing?

Gloria Melanie's most recent SEC Form 4 filing on Tracefour is dated Oct 9, 2026.

What is Gloria Melanie's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Gloria Melanie is listed as Chief Operating Officer.

What is Gloria Melanie's total buy and sell value in the current window?

Inside the rolling retention window, Gloria Melanie bought $0 and sold $1.7M based on SEC Form 4 filings.

What was Gloria Melanie's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 17,714 IMVT shares on 2026-06-26, worth $679K, per SEC Form 4 filings.